Genmab (Otc) (GMAB) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Genmab A/S has been actively purchasing its shares back under a program announced on March 15, 2024, with the aim to acquire up to DKK 3.5 billion worth by December 16, 2024. As of April 26, the company has executed several transactions, leading to the possession of 1,463,160 treasury shares, which equals 2.21% of Genmab’s total share capital and voting rights. The buy-back initiative aligns with the EU’s Market Abuse Regulation and Safe Harbour regulations, reaffirming Genmab’s commitment to its investment strategy and shareholder value.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.